Drawing for PLANTWISE

USPTO serial 97169310

PLANTWISE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
COHEN, ROBERT ANDREW
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PLANTWISE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003skin and body topical lotions for cosmetic useACTIVE
005dietary supplements; topical analgesic creams; probiotic supplements; nutritional supplementsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 18, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 18, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 18, 2023WOAGWITHDRAWAL OF ATTORNEY GRANTED
Sep 18, 2023WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED
Aug 30, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 30, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 30, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 15, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 27, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 27, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 27, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 27, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 27, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 20, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 20, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 31, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 13, 2022LOPRLETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Oct 13, 2022LOPTLETTER OF PROTEST EVIDENCE FORWARDED
Sep 7, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 7, 2022XAECEXAMINER'S AMENDMENT ENTERED
Sep 7, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 7, 2022GNEAEXAMINERS AMENDMENT E-MAILED
Sep 7, 2022CNEAEXAMINERS AMENDMENT -WRITTEN
Aug 30, 2022DOCKASSIGNED TO EXAMINER
Dec 16, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 16, 2021NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance